drugset / Trial / NCT04572698
A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）
RandomizedParallel-groupDouble-blindTreatment
Summary
A randomized, double-blind, parallel controlled, multicenter clinical trial to compare the efficacy and safety of LY09004 and EYLEA in the Treatment of Wet Age-related Macular Degeneration（wAMD)
Timeline
- Start
- 2020-11
- Primary completion
- 2023-06
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aflibercept | Protein / enzyme biologic | — | Other |
| Subject | LY09004 | Protein / enzyme biologic | — | Other |